We have located links that may give you full text access.
English Abstract
Journal Article
[Effect of bromocryptin in polycystic ovary syndrome].
Ten patients with polycystic ovarian disease and normoprolactinemia received bromocriptine 5 mg daily for up to 4 months. The following parameters were evaluated before treatment and at monthly intervals menstrual patterns, hirsutism score, weight, and blood pressure and LH, FSH, prolactine, unbound and total testosterone in plasma. In 5 out of 10 subjects with oligomenorhea or amenorhea normal menstruations were observed; 3 additional subjects got more frequent but not normal menstruation and 2 patients got pregnant. No changes in LH, FSH and androgens were observed. Prolactin levels fell significantly in all subjects. No clinical nor biochemical parameter predicted the improvement in menstrual patterns. Bromocriptine may have a place in the treatment of polycystic ovarian diseases with normoprolactinemia though its mechanism of action is unclear.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app